Chika Kawasaki
- Pathology and Forensic Medicine top 2%
- Immunology top 10%
- Oncology top 10%
- Surgery
- Developmental Neuroscience top 2%
- Co-authors
- Takashi KawasakiMasahiro KikuchiKoichi OhshimaMasanori OgataAkio ShigematsuJunji SuzumiyaTakeyoshi SataYoshitaka Inoue
- Topics
- Lymphoma Diagnosis and Treatment (14 papers)T-cell and Retrovirus Studies (9 papers)Immune Cell Function and Interaction (7 papers)
- Cited by
- Developmental NeuroscienceCritical Care and Intensive Care MedicinePathology and Forensic Medicine
- Partner nations
- JapanUnited States
In The Last Decade
Chika Kawasaki
43 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 102
- Pathology and Forensic Medicine 515
- Immunology 417
- Oncology 388
- Surgery 215
- Developmental Neuroscience 199
Countries citing papers authored by Chika Kawasaki
This map shows the geographic impact of Chika Kawasaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chika Kawasaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chika Kawasaki more than expected).
Fields of papers citing papers by Chika Kawasaki
This network shows the impact of papers produced by Chika Kawasaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chika Kawasaki. The network helps show where Chika Kawasaki may publish in the future.
Co-authorship network of co-authors of Chika Kawasaki
This figure shows the co-authorship network connecting the top 25 collaborators of Chika Kawasaki. A scholar is included among the top collaborators of Chika Kawasaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chika Kawasaki. Chika Kawasaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 9 | |
| 3 | 23 | |
| 4 | 30 | |
| 5 | 56 | |
| 6 | 8 | |
| 7 | 48 | |
| 8 | 2 | |
| 9 | 9 | |
| 10 | 11 | |
| 11 | 14 | |
| 12 | 1 | |
| 13 | 64 | |
| 14 | 11 | |
| 15 | 72 | |
| 16 | 16 | |
| 17 | 15 | |
| 18 | 144 | |
| 19 | 21 | |
| 20 | 3 |
About Chika Kawasaki
Chika Kawasaki is a scholar working on Immunology, Pathology and Forensic Medicine and Critical Care and Intensive Care Medicine, having authored 45 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (14 papers), T-cell and Retrovirus Studies (9 papers) and Immune Cell Function and Interaction (7 papers). The work is most often cited by research in Developmental Neuroscience (199 citations), Critical Care and Intensive Care Medicine (169 citations) and Pathology and Forensic Medicine (515 citations). Chika Kawasaki has collaborated with scholars based in Japan and United States. Frequent co-authors include Takashi Kawasaki, Masahiro Kikuchi, Koichi Ohshima, Masanori Ogata, Akio Shigematsu, Junji Suzumiya, Takeyoshi Sata, Yoshitaka Inoue, Junichi Ogata and Seiji Haraoka. Their work appears in journals such as Blood, Journal of Colloid and Interface Science and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.